-
Mashup Score: 0Use of systemic glucocorticoids and risk of breast cancer in a prospective cohort of postmenopausal women - BMC Medicine - 3 year(s) ago
Background Glucocorticoids could theoretically decrease breast cancer risk through their anti-inflammatory effects or increase risk through immunosuppression. However, epidemiological evidence is limited regarding the associations between glucocorticoid use and breast cancer risk. Methods We investigated the association between systemic glucocorticoid use and breast cancer incidence in the E3N…
Source: BMC MedicineCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
Research from @AgneesFournieer @IARCWHO @GustaveRoussy reporting the use of systemic #glucocorticoids and risk of #breastcancer in a prospective #E3N cohort of postmenopausal #women Read it here: https://t.co/zNIzE74sVR https://t.co/IceU5daZqO